Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants ...
The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coliConjugateEscherichia coliO antigenUrinary tract infectionVaccineObjectives: In this 'how it was done' narrative review, we provide a description of, and context for, the early development of...